1. Home
  2. ITRM vs AHT Comparison

ITRM vs AHT Comparison

Compare ITRM & AHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • AHT
  • Stock Information
  • Founded
  • ITRM 2015
  • AHT 2003
  • Country
  • ITRM Ireland
  • AHT United States
  • Employees
  • ITRM N/A
  • AHT N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • AHT Real Estate Investment Trusts
  • Sector
  • ITRM Health Care
  • AHT Real Estate
  • Exchange
  • ITRM Nasdaq
  • AHT Nasdaq
  • Market Cap
  • ITRM 49.5M
  • AHT 49.3M
  • IPO Year
  • ITRM 2018
  • AHT 2003
  • Fundamental
  • Price
  • ITRM $1.75
  • AHT $8.00
  • Analyst Decision
  • ITRM Strong Buy
  • AHT
  • Analyst Count
  • ITRM 1
  • AHT 0
  • Target Price
  • ITRM $5.00
  • AHT N/A
  • AVG Volume (30 Days)
  • ITRM 1.6M
  • AHT 50.3K
  • Earning Date
  • ITRM 11-14-2024
  • AHT 11-05-2024
  • Dividend Yield
  • ITRM N/A
  • AHT N/A
  • EPS Growth
  • ITRM N/A
  • AHT N/A
  • EPS
  • ITRM N/A
  • AHT 1.83
  • Revenue
  • ITRM N/A
  • AHT $1,215,615,000.00
  • Revenue This Year
  • ITRM N/A
  • AHT N/A
  • Revenue Next Year
  • ITRM N/A
  • AHT N/A
  • P/E Ratio
  • ITRM N/A
  • AHT $4.71
  • Revenue Growth
  • ITRM N/A
  • AHT N/A
  • 52 Week Low
  • ITRM $0.81
  • AHT $5.20
  • 52 Week High
  • ITRM $3.02
  • AHT $20.80
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 45.98
  • AHT 52.45
  • Support Level
  • ITRM $1.78
  • AHT $8.07
  • Resistance Level
  • ITRM $1.95
  • AHT $8.80
  • Average True Range (ATR)
  • ITRM 0.30
  • AHT 0.63
  • MACD
  • ITRM -0.10
  • AHT -0.12
  • Stochastic Oscillator
  • ITRM 0.00
  • AHT 32.38

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About AHT Ashford Hospitality Trust Inc

Ashford Hospitality Trust Inc. is a real estate investment trust that invests in full-service upscale and upper-upscale hotel properties in the U.S. The company owns and operates its assets through its operating partnership, Ashford Hospitality Limited Partnership. All of its hotels are located across the U.S. and operate under the Marriott, Hilton, Hyatt, Crowne Plaza, and Sheraton brands. Ashford's sole segment is Direct Hotel Investments, through which it owns hotels by acquisition or development. Ashford also provides rest estate investment services, such as mezzanine financing, first mortgage financing, and sales-leaseback transactions. Its revenue streams include Room revenue, Food and beverage revenue, and Other revenue. Room revenue accounts for the majority of total revenue.

Share on Social Networks: